AtheroGenics AGI-1067 Development In Diabetes Takes Step Forward
This article was originally published in The Pink Sheet Daily
Executive Summary
Positive diabetes data, coupled with earlier cardiovascular outcomes, could facilitate approval of AGI-1067 in era of cautious FDA, firm says.